Author Question: The Bayley Scales of Infant Development Second Edition (BISD-II) (Bayley, 1993) is a commonly used ... (Read 39 times)

laurencescou

  • Hero Member
  • *****
  • Posts: 593
The Bayley Scales of Infant Development  Second Edition (BISD-II) (Bayley, 1993) is a commonly used standardized assessment tool that is designed to assess students through age 8.
 
  Indicate whether the statement is true or false

Question 2

IDEA does not define the specific kinds of assessment used in the comprehensive evaluation.
 
  Indicate whether the statement is true or false



adammoses97

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

F

Answer to Question 2

T



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Signs of depression include feeling sad most of the time for 2 weeks or longer; loss of interest in things normally enjoyed; lack of energy; sleep and appetite disturbances; weight changes; feelings of hopelessness, helplessness, or worthlessness; an inability to make decisions; and thoughts of death and suicide.

Did you know?

Blastomycosis is often misdiagnosed, resulting in tragic outcomes. It is caused by a fungus living in moist soil, in wooded areas of the United States and Canada. If inhaled, the fungus can cause mild breathing problems that may worsen and cause serious illness and even death.

Did you know?

For about 100 years, scientists thought that peptic ulcers were caused by stress, spicy food, and alcohol. Later, researchers added stomach acid to the list of causes and began treating ulcers with antacids. Now it is known that peptic ulcers are predominantly caused by Helicobacter pylori, a spiral-shaped bacterium that normally exist in the stomach.

Did you know?

Vampire bats have a natural anticoagulant in their saliva that permits continuous bleeding after they painlessly open a wound with their incisors. This capillary blood does not cause any significant blood loss to their victims.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library